Glenmark announces launch of Favipiravir to treat Covid patients - The Indian Express 21-Jun-2020

on June 21, 2020

Glenmark announces launch of Favipiravir to treat Covid patients - The Indian Express

Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu® the first oral Favipiravir-approved medication in India for the treatment of Covid-19, officials said at a press conference organised online.